Molecular Partners AG at Cowen Healthcare Conference (Virtual) Transcript
Great. Well, thanks to Patrick, Andreas and Seth for joining both Stacy and Georgi and I on this conversation.
These are -- obviously, we go back a long way, all the way to the IPO. And there's been evolution in the story, but the consistency here is clearly constant innovation. And you all, to your credit, have I think pushed this company tremendously far down the path here. And you've done it with a lot of efficiency, so to -- credit to you all.
Questions & Answers
And I think that's something maybe we should highlight in the Q&A, as to where you've gotten into the level of lack of burn, I would say, to get to where you were, but maybe, Patrick, for folks that are joining that are newer to the story, just briefly, before we get into the -- to more of the details, why don't we talk a little bit about an overview of your DARPin
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |